Showing results (231-240 of 341) with videos related to

Sort By:
Pageof 35
Clinical Cardiology|November 13, 2019
Predicting risk of cardiovascular events 1 to 3 years post-myocardial infarction using a global registryStuart J Pocock, David Brieger, John Gregson, et al.
European Heart Journal|July 5, 2019
Efficacy and safety of alirocumab and evolocumab: a systematic review and meta-analysis of randomized controlled trialsPaul Guedeney, Gennaro Giustino, Sabato Sorrentino, et al.
Diabetes Research and Clinical Practice|March 25, 2019
Treatment of type 2 diabetes mellitus worldwide: Baseline patient characteristics in the global DISCOVER studyMarilia B Gomes, Wolfgang Rathmann, Bernard Charbonnel, et al.
Journal of Cardiology|December 3, 2021
Determinants of long-term dual antiplatelet therapy use in post myocardial infarction patients: Insights from the TIGRIS registryJuan J Russo, Andrew T Yan, Stuart J Pocock, et al.
European Heart Journal|January 18, 2021
Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trialMilton Packer, Stefan D Anker, Javed Butler, et al.
European Journal of Heart Failure|July 14, 2025
Coordinated expression of BMP10/ALK1/endoglin-proteins that drive embryonic cardiac and vascular morphogenesis-in patients with heart failure: The EMPEROR ProgramMilton Packer, Javed Butler, João Pedro Ferreira, et al.
The New England Journal of Medicine|May 8, 2009
Paclitaxel-eluting stents versus bare-metal stents in acute myocardial infarctionGregg W Stone, Alexandra J Lansky, Stuart J Pocock, et al.
The New England Journal of Medicine|February 14, 2007
Safety and efficacy of sirolimus- and paclitaxel-eluting coronary stentsGregg W Stone, Jeffrey W Moses, Stephen G Ellis, et al.
JACC. Heart Failure|March 7, 2023
Comparison of Investigator-Reported and Centrally Adjudicated Heart Failure Outcomes in the EMPEROR-Reduced TrialPeter Carson, John R Teerlink, Michel Komajda, et al.
European Journal of Heart Failure|April 1, 2024
Body mass index and cardiorenal outcomes in the EMPEROR-Preserved trial: Principal findings and meta-analysis with the DELIVER trialNaveed Sattar, Javed Butler, Matthew M Y Lee, et al.
Pageof 35